Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1431-1440 of 1,873) with videos related to

Pageof 188
Sort By:
European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.
JACC. Asia|December 14, 2023
Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF RegistryKanako Teramoto, Wouter Ouwerkerk, Wan Ting Tay, et al.
European Heart Journal|September 2, 2014
Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trialFaiez Zannad, Gaetano M De Ferrari, Anton E Tuinenburg, et al.
Journal of the American Heart Association|April 7, 2018
Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study)Larisa G Tereshchenko, Nona Sotoodehnia, Colleen M Sitlani, et al.
Circulation|September 29, 2024
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF TrialKieran F Docherty, Alasdair D Henderson, Pardeep S Jhund, et al.
JACC. Heart Failure|April 15, 2025
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
European Journal of Heart Failure|December 2, 2017
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HFUlrik M Mogensen, Lars Køber, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart FailureMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
Journal of Medical Genetics|September 20, 2015
Mutations in human homologue of chicken talpid3 gene (KIAA0586) cause a hybrid ciliopathy with overlapping features of Jeune and Joubert syndromesMay Christine V Malicdan, Thierry Vilboux, Joshi Stephen, et al.
Pageof 188

Showing results (1431-1440 of 1,873) with videos related to

Sort By:
Pageof 188
European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.
JACC. Asia|December 14, 2023
Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF RegistryKanako Teramoto, Wouter Ouwerkerk, Wan Ting Tay, et al.
European Heart Journal|September 2, 2014
Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trialFaiez Zannad, Gaetano M De Ferrari, Anton E Tuinenburg, et al.
Journal of the American Heart Association|April 7, 2018
Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study)Larisa G Tereshchenko, Nona Sotoodehnia, Colleen M Sitlani, et al.
Circulation|September 29, 2024
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF TrialKieran F Docherty, Alasdair D Henderson, Pardeep S Jhund, et al.
JACC. Heart Failure|April 15, 2025
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
European Journal of Heart Failure|December 2, 2017
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HFUlrik M Mogensen, Lars Køber, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart FailureMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
Journal of Medical Genetics|September 20, 2015
Mutations in human homologue of chicken talpid3 gene (KIAA0586) cause a hybrid ciliopathy with overlapping features of Jeune and Joubert syndromesMay Christine V Malicdan, Thierry Vilboux, Joshi Stephen, et al.
Pageof 188